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Abstract  
Background: 
It is widely believed that for allergic rhinitis and asthma, avoidance of specific triggers can improve 
symptom control.  Whilst many children with asthma or rhinitis are sensitised to airborne allergens, 
primary care diagnostic and management decisions are often made without a detailed history of the 
allergic triggers or allergy testing.  Thus, treatment decisions are empirical and allergen avoidance 
advice is either not given or, if given, not tailored to the child’s sensitivities.   
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Objective: 
To ascertain whether allergy assessment and tailored advice in General Practice enhances outcomes 
of children with asthma and rhinitis. 
Method:  
Pragmatic RCT of allergy intervention (structured allergy history, skin prick testing and appropriate 
allergy avoidance advice) versus usual care in children with asthma and/or rhino-conjunctivitis.  A 
blinded observer assessed outcomes at 12 months.  Main outcome measures were symptom scores 
and disease-specific health-related QoL.  Secondary outcomes were health care utilisation, days 
unable to pursue usual activities, and self-rated improvement. 
Results:  
335 participants were randomised to formal allergy assessment or normal care. There were no 
differences in participants’ demographic or clinical characteristics at baseline (all p>.05). At 12 months, 
participants receiving the allergy intervention had fewer rhinitis symptoms (MD -3.14, 95% CI -6.01, -
0.81) and an improvement in QoL (MD -0.50, 95% CI 0.32, 0.68).  There were no significant changes in 
asthma symptoms, health care utilisation or number of days unable to pursue usual activities.  
Conclusion: 
Amongst children with known asthma and/or rhinitis in primary care, taking a structured allergy 
history with skin prick testing and tailored advice on allergy avoidance resulted in reduced symptoms 
of rhinitis and improved QoL.  
Key words:  
asthma, allergy assessment, evaluation, quality of life, rhinitis, skin prick testing, symptoms 
 
Running title: Allergy intervention for children with asthma or rhinitis  
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Source of Funding:  Project was funded by NIHR Research for Patient Benefit scheme.   ALK-Abello 
provided the skin test materials (allergens and lancets) free of charge. 
 
Abbreviations:  
FEV1          
 
Forced Expiratory Value in one second 
 FVC 
 
Forced Vital Capacity
GP 
 
General Practitioner
PN               
 
Practice Nurse
PEFR Peak Expiratory Flow Rate
QoL            
 
Quality of Life
SPT 
 
Skin Prick Test
RCT              
 
Randomised Controlled Trial 
 
Background 
Allergic diseases are a common reason for consulting UK General Practitioners, representing up to 6% 
of all consultations and accounting for 10% of primary care prescribing costs. 
1
   Asthma & rhinitis are 
two of the most common chronic childhood diseases in the UK. 
2
  These conditions substantially 
impact on children’s quality of life (QoL) 
3
 and their school performance. 
4 
  The majority of children 
with asthma and/or rhinitis have underlying allergies. In patients with allergies, avoidance of specific 
triggers can reduce symptoms and the need for medication. However, most primary care diagnostic 
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and management decisions are made without obtaining a detailed history or performing allergy tests.  
Thus, treatment decisions are empiric and allergen avoidance advice is either not given or is not 
specific to the child’s problem.  It has been suggested that the introduction of allergen-specic testing 
such as skin prick tests (SPT) into General Practice could improve the cost-effectiveness of asthma & 
rhinitis care through appropriate targeting of medication and allergy avoidance advice. 
Recent reviews of allergy services have highlighted major shortcomings of the allergy services 
provided throughout the UK. 
1 
  The solution to this deficit lies in part with the development of a 
larger cadre of allergy specialists, but there is also a need to develop improved allergy care within 
primary care services. Descriptive studies in adults confirm the feasibility of allergy assessment in a 
non-specialist setting and its potential to avoid inappropriate allergy avoidance advice. 
5,6
   However, 
a subsequent randomised trial of formal allergy assessment in adults with established asthma and 
rhinitis did not show any significant improvements in symptoms and outcomes. 
7
  As these previous 
studies have only looked at adult patients it would be unwise to extrapolate the findings to the 
paediatric population without further age-specific studies.  
In this trial we investigated whether assessment of allergic status (structured allergy history and skin 
prick testing) in General Practice together with providing appropriate advice on allergy avoidance 
enhances the health and wellbeing of children with asthma or rhinitis.  
 
 
 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
Methods 
Setting: 
General practices in two counties in the South East of England (East Sussex and West Sussex). 
 
Design:  
Pragmatic single-blinded randomised controlled trial (RCT) of allergy intervention (structured allergy 
history + skin prick testing (SPT) + appropriate advice on allergy avoidance).  After baseline 
assessment, 335 children aged 6-16 years were randomised to receive the allergy intervention or 
usual care.   
 
Study Enrolment:  
Twenty general practices used their electronic patient records to identify patients aged 6 to 16 years 
with a diagnostic label of asthma, rhinitis or hay fever.  Children were excluded if they had had SPT in 
the preceding two years, were suffering from a serious chronic or terminal illness, their parents did 
not speak English, or it was known that the family were moving away from the area in the next 12 
months.  To ensure that the diagnoses were still active, children were only invited if they had one or 
more problem-related consultations in the preceding year.  The General Practitioner’s letter of 
invitation included two information sheets, one for the parents and another for the child or 
adolescent.  A postage paid envelope was provided for response.  Those parents who expressed 
interest in in the study were contacted by the study-trained general practice nurse to confirm 
eligibility.  Prior to the baseline assessment appointment parents and children completed a 
questionnaire booklet about rhinitis and asthma symptoms 
8 
and condition-related QoL. 
9
 Consent and 
assent to participate in the trial were obtained by the practice nurse. The parent or guardian of each 
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child signed a consent form and, if the child was aged between 13-16 years, their agreement to 
participate was confirmed by completion of a form of assent. Recruitment was conducted between 
November 2010 and October 2011. 
Baseline information: 
Data were collected on demographics (age, gender, ethnicity), clinical data (height, weight and 
diagnoses), use of primary and secondary health services for asthma and rhinitis related problems in 
preceding 12 months and the number of days in the last month on which the child was unable to go to 
school or undertake usual activities because of ill health.  Spirometry (FEV1, peak expiratory flow and 
FVC) was repeated three times using a standardised method and the best of three values were utilised 
in  analysis
10
. 
 
Randomisation: 
Children were randomised to formal allergy assessment or usual care (empirical treatment for 12 
months and the opportunity for a structured allergy assessment on trial completion).  
Randomisation was blocked and stratified by General Practice.  
 
 Intervention  
The intervention was a structured allergy history, skin prick testing, test interpretation and relevant 
advice on allergy avoidance.  The general practice nurses all received three hours training in 
structured allergy assessment (history, skin prick testing and its interpretation) and were provided 
with written instructions on skin prick testing and access to senior clinicians (AJF or SM) if needed.  
 A structured allergy history was taken and documented using a proforma. The questions reviewed 
information on self-reported allergies, the duration and severity of asthma and/or rhinitis, 
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exacerbating factors, personal history of atopy, history of atopy in first degree relatives (parents and 
siblings), exacerbating circumstances (seasonality, time of day, indoors vs outdoors), exposure to pets, 
dust and mould. 
Skin prick testing (SPT) to seven common aero-allergens was performed using standardised allergy 
extracts (house dust mite (Dermatophagoides pteronyssinus), tree pollen, mixed grass pollens, cat 
dander, dog dander) and two moulds (Aspergillus and Alternaria alternata).  Positive (histamine) and 
negative (saline) controls were used.   SPTs were performed on the volar surface of the forearm with 
1mm-prick lancets.  Wheal diameters were recorded after 15 minutes, as the arithmetic mean of the 
maximum diameter and perpendicular diameter.  A mean wheal diameter greater than or equal to 
3mm was considered a positive result (99% specificity).
11
  
Advice on allergen avoidance was provided following interpretation of allergy history and SPT results.  
A positive history and positive skin result were needed for a diagnosis of allergy. Relevant allergen 
avoidance advice was given verbally and reinforced with a leaflet.  The leaflets were the same as those 
used in the local hospital allergy clinic and were specific to tree and grass pollens, to pets (including 
cats and dogs), to house dust mite or to mould. 
 
Outcome measures  
Primary outcomes were asthma and rhinitis symptom scores and disease-specific health-related 
QoL.  Secondary outcomes were health care utilisation, days unable to pursue usual activities and 
parental- and self-rated improvement. 
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Rhino-conjunctivitis and asthma symptom score 
8
 
This score assesses symptoms of asthma and rhino-conjunctivitis.  The symptoms of these two 
interdependent syndromes are scored in two domains; 11 items form the rhinitis scale, which asks 
about eye (3), nose (4) and sinus symptoms (4), and nine items form the asthma scale, which 
assesses day and night experiences of cough (2), wheeze (2), sputum production (2) and shortness of 
breath/chest tightness (3).  All symptoms are scored on a five point scale from none (0) to severe (4). 
Items are weighted equally and are summed to create a score for each domain and a total symptom 
score, with higher scores indicating more symptoms. 
 
Paediatric Allergic Disease Quality of Life Questionnaire (PADQLQ) 
9 
 This self-administered health-related QoL questionnaire encompasses effects of allergic disease on a 
child's or teenager's eyes, ears, nose, lungs, skin, emotions, and everyday activities. The questionnaire 
has 26 items spread over 3 domains; practical problems (8), symptoms (15) and emotional problems 
(3).  Patients score their experiences of their previous week on a 7-point scale (0=not troubled to 
6=extremely troubled).  Individual items are weighted equally and the questionnaire is analysed 
directly from the scores recorded.  Results were expressed as the mean score per domain.  Overall 
QoL is estimated from the mean score of all items, with higher scores indicating greater impairment of 
QoL.   
 
Frequency and duration of follow up 
Control and intervention participants were followed up at monthly intervals for one year from their 
baseline visit with a questionnaire that asked about the number of days that they had been unable to 
go to school or pursue normal activities.   After 12 months all participants were invited to a follow up 
appointment with a research nurse who was blinded to the study arm they were allocated to.  At this 
visit the participants again completed symptom scores and the allergic disease QoL questionnaire and 
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spirometry.  Once the final assessment was complete, participants in the control arm were able to 
undergo formal allergy assessment if they wished.  
 
Sample size calculation  
 The sample size calculation, based on QoL measurements, estimated a sample size of 105 
participants in each arm would be sufficient to detect a clinically significant reduction of 0.5 
(assuming a standard deviation of 1.1) at the 5% level of significance with 90% power.  This sample 
size was estimated to be sufficient to detect a 15 percent point difference in rates for the binary 
response variable assessing patients’ subjective assessment of improvement (improved/not 
improved).  Allowing for 33% loss to follow up required 140 recruits in each arm. 
 
Data Analysis 
Data was manually entered into SPSS version 22, cleaned and all variables assessed for outliers. A 
frequency check was performed for the response variables and any discrepancies were checked 
against the case records.  Twenty per cent of the data was double entered: the pre-defined 
minimum accuracy rate was 98%, and as this was achieved no further double data entry was 
undertaken. Baseline demographic characteristics were compared between the intervention and 
control groups using t-tests for continuous data and chi-square for binary data. Where the data did 
not satisfy the parametric assumptions non-parametric tests were applied. The difference in  pre-
test and post-test measures for the Likert scale data QoL instrument and symptom scores were 
analysed using Mann Whitney U Test. The comparison between the intervention and control groups 
were analysed using Analysis of Covariance (ANCOVA) controlling for baseline scores on each 
outcome. The significance level for all tests was p< 0.05. 
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Ethical approval for the study was obtained from the Scotland A Research Ethics Committee (ref: 
02/10/013).  The protocol for this study was published on the UK CRN website (trial number 10034).  
 
Results 
Three hundred and thirty five participants were recruited from 19 General Practices in Sussex and 
randomised, 167 patients to the control arm and 168 to the intervention arm (Figure 1).   The 
demographic characteristics of the two groups showed no significant differences in age, gender, 
ethnicity, height or weight. Intervention and control participants were also comparable with respect 
to clinical characteristics and use of health services for asthma and or rhinitis in the preceding 12 
months (Table 1). The majority of participants had both asthma and rhinitis (54%), 22% rhinitis alone 
and 24% asthma alone.  
Three hundred and thirteen participants (93%) completed the trial. Completers and non-completers 
did not differ on any demographic or clinical characteristics. Compared to controls, and controlling 
for baseline scores, intervention participants reported a significant reduction in rhinitis specific 
symptoms (MD -2.19, 95% CI -3.88, -0.50) and overall symptoms (MD -3.14, 95% CI -6.01, -0.81), but 
not asthma specific symptoms (Table 2).  Intervention participants also reported significant 
reductions in impaired QoL both overall (MD -0.50, 95% CI -0.68, -0.32), and in the separate domains 
of practical problems, symptoms and emotional problems (Table 2).  The QoL results have clinical 
importance, as well as statistical significance, as the minimal clinical important difference for the 
PADQLQ is 0.3. 
 
On completion, there was no significant difference between intervention and control participants and 
their parents reporting that either asthma or rhinitis/hayfever had improved, worsened or stayed the 
same (Table 3).Similarly there were no significant differences between intervention and controls in 
respect to numbers of days unable to pursue usual activities in the last month (MD -0.08, 95%CI -0.16, 
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0.00), GP consultations (OR 0.73, 95% CI 0.46, 1.14) or hospital attendances in the previous 12-months 
(OR 0.83, 95% CI 0.37, 1.86). The majority (86%) of intervention participants stated they would 
recommend skin prick testing to a friend.  
At baseline, 71% participants suspected an allergic trigger for their symptoms.  The most common 
suspected trigger was grass pollen (46%), followed by HDM (37%), cat (30%), tree pollen (23%), dog 
(18%) or mould (7%).   After formal allergy assessment there were 52 children (31%) in whom new 
triggers were identified, i.e. a trigger identified on structured history and confirmed by SPT that had 
not been suspected by the parent or child  when self-reporting suspected allergies (Figure 2).  Thirty 
six participants had one new trigger identified, 15 had two new triggers and one had three. Conversely 
suspected triggers were not confirmed by skin prick testing in 69 patients (41%).  Overall 127 
participants (76%) had one or more aeroallergen trigger. 
 
Discussion  
Statement of principal findings 
In this pragmatic single blind randomised controlled trial of an allergy intervention (structured 
allergy history & skin prick testing & tailored advice on allergy avoidance) versus usual care in 
children with a working diagnosis of asthma and/or rhino-conjunctivitis at 12-months, participants 
receiving the allergy intervention reported a reduction in symptoms (MD -3.14, 95% CI -6.01, -0.81) 
and an improvement in QoL (MD 0.50, 95% CI 0.32, 0.68).  When symptoms were analysed 
separately for rhinitis- and asthma-specific symptoms, only the observed reduction in rhinitis 
symptoms was statistically significant. There were no significant differences in the secondary 
outcome measures of health service utilisation, days unable to pursue normal activities, or perceived 
benefit. 
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Strengths and weaknesses  
The study was rigorously designed and participants were followed up for one year to reduce the 
impact of seasonal variation of symptoms.  We recognise that randomising by patient rather than by 
practice may introduce contamination and reduce the differences observed between groups.  
However, there is very little evidence that contamination actually occurs in trials when practitioners 
use a structured approach to health care delivery.  Trials of the management of acute minor illness 
conducted in primary care
12
 and the Family Heart Study
13
 found no evidence of intra-practice 
contamination. The recruitment of only one child from each household also reduced the risk of 
controls being influenced by the intervention.  Nonetheless we acknowledge that those randomised to 
routine care may have become more attentive to allergen avoidance after recruitment. 
The impact of the intervention may have been reduced as we did not review and confirm the 
diagnosis of asthma and/or rhinitis before intervention.  It is recognised that environmental tobacco 
smoke can impact on symptom provocation and treatment responses
14
 but as we did not ask about 
this exposure at the baseline assessment, we cannot comment on the equivalence of our two groups 
in this respect.  Allergen avoidance behaviour was not assessed so it is not known to what extent the 
intervention impacted on this behaviour.  However, ultimately it is the impact of an intervention on 
patient outcomes (symptom control and quality of life), rather than processes (such as allergen 
avoidance), that are of importance.  We recognise that a negative skin prick test, ruling out an allergic 
aetiology, may be beneficial but does not require allergen avoidance.   
In this study we used an existing nurse member of the primary care team to provide the intervention 
rather than an external peripatetic nurse.  We envisaged that this is how such an intervention could be 
readily incorporated in practice if the intervention was worthwhile, given the universal involvement of 
PNs in the management of chronic disease, including asthma.  Our intervention model also fits with 
the diversification of providers that has been promoted as an approach towards providing an 
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accessible and sustainable allergy service and allowing specialists to focus their expertise on patients 
with complex problems.
15
 
The intervention was focussed on formal allergy assessment, leading to tailored advice on removal 
or avoidance of allergic triggers.  It did not include other characteristics of good practice such as age-
appropriate written personal management plan, information on charities, websites and patient 
support groups and/or patient/parent education, all of which are incorporated into the Royal 
College of Paediatrics and Child Health care pathways.
16 
  A case could also be made for professional 
education in parallel, as it is well recognised that allergy training is lacking in both undergraduate 
and post graduate medical curricula in the UK. 
17, 18 
 
Reasons for a negative outcome in asthma symptoms must include the possibility that 12 months is 
not sufficient to achieve the full impact of avoidance measures (such as removing a pet from the 
household).  Whilst extreme forms of allergen avoidance have been effective in other studies, for 
example, admission to hospital for prolonged periods or relocation to altitude, where house dust 
mites cannot grow due to the low absolute level of humidity 
19, 20   
there is very little evidence of any 
impact on asthma symptoms from the type of allergen avoidance measures that are practical in 
suburban homes at sea level. 
 20, 21   
The recruitment of this broad spectrum of patients was 
appropriate as it was a pragmatic trial designed to assess the impact of the intervention in routine 
practice in the community.
22
  The invitations to participate in the trial were based on the diagnostic 
codes without any additional screening for symptoms severity.  It is possible that the impact of the 
intervention might have been more pronounced if it had focused on children with more severe 
disease, or only children with rhinitis.  Further trials and economic evaluations are needed to 
ascertain whether the benefits of a structured allergy intervention could be of greater benefit if used 
in a more targeted manner in primary care.  In conclusion, this well constructed, single-blind, 
pragmatic study supports the introduction of a general practice-based allergy assessments for 
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children with asthma and /or rhinitis to reduce the symptoms of rhinitis and to improve health 
related QoL.    
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Table 1: Baseline demographic and clinical characteristics for intervention and control participants  
 Control 
N=167 
Intervention
N= 168 
P value
(t-
test/χ2) 
Total 
N=335 
Demographic 
characteristics 
Mean age in years  
(SD, range) 
11.56  
(2.78, 6-16) 
11.26 
(2.72, 6-16) 
.27 11.43 
(2.75) 
Gender 
% male 
56.3 57.7 .88
 
57.0 
Ethnicity 
% white British 
91.0 88.7 .37 89.9 
Clinical characteristics 
Mean height in cm (SD) 151.20 (16.48) 149.98 (15.97) .49 150.59 
(16.21) 
Mean weight  in kg (SD) 45.12 (15.36) 44.97 (16.60) .93 45.05 
(15.97) 
% Rhinitis only (seasonal 
+/or perennial rhinitis) 
21.6 22.2 21.9 
% Asthma & Rhinitis 52.1 55.7 53.9 
% attending hospital 
(inpatient,  outpatient or 
A&E visit) for 
asthma/rhinitis related 
problem in previous 12 
months  
7.2 6.0 .83 6.6 
% attending GP  or 
Practice nurse in 
previous 12 months  
99.4 100.0 .49* 99.7 
Mean (SD) number of 
days in last month when 
unable to pursue usual 
activities due to 
asthma/rhinitis 
.62 (1.75) .72 (2.51) .67 .67 
(2.16) 
Lung Function 
FEV1 %  predictedFVC %  
predicted 
 
88.54 
(14.65)88.21 
(14.64) 
 
87.15 
(15.83)86.92 
(16.55)   
.41 
.45 
*Fisher’s exact test 
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Table 2:  Symptom scores assessed by Wasserfallen Symptom Score Questionnaire (SSQ) and disease 
specific quality of life questionnaire (PADQLQ). Results are presented for each domain and overall, 
pre and post-intervention (n=313) 
 
Symptom scores 
  Intervention 
Mean (SD) 
Control 
Mean (SD) 
Mean 
difference 
[95% CI] 
P  
(ANCOVA) 
 
Rhinitis 
Baseline 11.69 (8.17) 11.77 (8.08) -2.19 
[-3.88, -0.50] 
.005 
 Post intervention 8.57 (7.18) 10.76 (8.04)
 
Asthma 
Baseline 5.44 (6.06) 6.19 (5.80) -1.24 
[-2.51, 0.03] 
.115 
 Post intervention 4.25 (5.41) 5.49 (6.03)
 
Overall 
score 
Baseline 17.13 (12.18) 17.97 (11.48)
-3.41 
[-6.01, -0.81] 
.010 
 
Post intervention 12.83 (11.25) 16.24 (12.22)
Quality of Life scores 
Practical 
problems 
Baseline 1.11 (1.00) 1.30 (.96) -0.34 
[-0.54, -0.14] 
.004 
 Post intervention 0.74 (.78) 1.08 (.99)
Symptoms Baseline 1.31 (1.05) 1.49 (.94) -0.35 
[-0.56, -0.14] 
.004 
 Post intervention 1.00 (.87) 1.35 (1.03)
Emotional 
problems 
Baseline 0.85 (1.13) .97 (1.10) -0.26 
[-0.47, -0.05] 
.037 
 Post intervention 0.59 (.86) .85 (1.01)
Overall 
score 
Baseline 1.20 (.97) 1.37 (.89) -0.50 
[-0.68, -0.32] 
.002 
Post intervention 0.87 (.77) 1.37 (.89)
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Table 3:  Self- and parental -assessment retrospective, subjective assessment of asthma, rhinitis or 
hay fever during the 12 months of the trial   
  Intervention 
(n=158) 
Control
 (n=155) 
P
(Kendall’s Tau) 
Asthma 
Worsened 34 32 
 
.492 
Same 6 13 
Improved 118 109 
N/A 0 1 
 
Rhinitis/ 
hayfever 
Worsened 38 45 
 
.727 
Same 19 13 
Improved 100 97 
N/A 1 0 
 
 
Asthma 
Worsened 31 27 
 
.466 
Same 2 13 
Improved 110 99 
N/A 15 16 
 
 
Rhinitis/ 
hayfever 
Worsened 33 36 
 
.393 
Same 24 23 
Improved 84 76 
N/A 17 20 
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